TARA Q4 2021 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TARAProtara Therapeutics, Inc.

$228M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$10M

Net Income

-$10M

EPS (Diluted)

$-0.91

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$173M

Total Liabilities

$11M

Stockholders' Equity

$162M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$10M	-$9M	-14.9%
Net Income	-$10M	-$9M	-16.1%